AAV -vectors for use in gene therapy of choroideremia

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9834788
APP PUB NO 20140107185A1
SERIAL NO

14000836

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to gene therapy for treatment or prevention of choroideremia.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • OXFORD UNIVERSITY INNOVATION LIMITED

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
During, Matthew John Columbus, US 4 13
Maclaren, Robert Oxford, GB 15 18
Seabra, Miguel London, GB 4 13

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 5, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 5, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00